ANTI-HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (HENT1) ANTIBODIES AND METHODS OF USE THEREOF
摘要
This invention provides monoclonal antibodies that recognize hENT1. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and/or prophylactic in disorders associated with aberrant hENT1 expression and/or activity.
申请公布号
EP2582724(A4)
申请公布日期
2014.05.28
申请号
EP20110795257
申请日期
2011.06.16
申请人
CLAVIS PHARMA ASA;THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
发明人
SANDVOLD, MARIT, LILAND;CASS, CAROL, E.;YOUNG, JAMES, D.;MYHREN, FINN
